# Phase 6.5 Adversarial Review Changelog

**Paper:** Dose-Response Relationships in LLM Data Curation
**Review Date:** 2026-08-28

---

## Summary

| Round | Changes Made |
|-------|--------------|
| R1 | 2 edits (Abstract, Results) |
| R2 | 0 edits (no issues found) |

---

## Round 1 Changes

### R1-001: Mock Evaluation Caveat (MAJOR)

**Issue:** Mock evaluation caveat (1/2000 scale) mentioned only in Discussion; readers may misunderstand improvement magnitude as production-ready.

**Files Modified:**

#### 1. `paper/sections/00_abstract.md`

**Before:**
```
...demonstrate 1.32% improvement over industry-standard defaults. Scale transfer...
```

**After:**
```
...demonstrate 1.32% improvement over industry-standard defaults at proof-of-concept scale. Scale transfer...
```

#### 2. `paper/06_paper.md` (Abstract)

Same change as above.

#### 3. `paper/06_paper.md` (Section 5.6)

**Before:**
```
| P3: Scale transfer ±20% | SUPPORTED | Transfer ratio 0.85 |

All three core predictions received experimental support under PoC conditions.
```

**After:**
```
| P3: Scale transfer ±20% | SUPPORTED | Transfer ratio 0.85 |

**Note:** All results obtained at proof-of-concept scale (5M-10M tokens, mock evaluation). Effect magnitudes are directional; full-scale replication required for production deployment.

All three core predictions received experimental support under PoC conditions.
```

---

## Round 2 Changes

No changes required. All numerical claims verified against Phase 4 validation files.

---

## Files Modified (Summary)

| File | R1 | R2 | Total |
|------|----|----|-------|
| paper/sections/00_abstract.md | 1 | 0 | 1 |
| paper/06_paper.md | 2 | 0 | 2 |

---

*Generated: 2026-08-28T16:30:00Z*
